{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:52:48Z","timestamp":1790610768507,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00417-019-04574-x","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T08:04:30Z","timestamp":1576829070000},"page":"621-628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Increased expression of periostin and tenascin-C in eyes with neovascular glaucoma secondary to PDR"],"prefix":"10.1007","volume":"258","author":[{"given":"Keijiro","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri-ichiro","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"4574_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000431196","volume":"55","author":"SJ Havens","year":"2016","unstructured":"Havens SJ, Gulati V (2016) Neovascular glaucoma. Dev Ophthalmol 55:196\u2013204","journal-title":"Dev Ophthalmol"},{"issue":"2","key":"4574_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/08820530902800801","volume":"24","author":"TA Shazly","year":"2009","unstructured":"Shazly TA, Latina MA (2009) Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol 24(2):113\u2013121","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"4574_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ajo.2010.03.016","volume":"150","author":"R Kohno","year":"2010","unstructured":"Kohno R, Hata Y, Mochizuki Y, Arita R, Kawahara S, Kita T, Miyazaki M, Hisatomi T, Ikeda Y, Aiello LP, Ishibashi T (2010) Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection. Am J Ophthalmol 150(2):223\u2013229 e221","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"4574_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0161-6420(83)34520-6","volume":"90","author":"T John","year":"1983","unstructured":"John T, Sassani JW, Eagle RC Jr (1983) The myofibroblastic component of rubeosis iridis. Ophthalmology 90(6):721\u2013728","journal-title":"Ophthalmology"},{"key":"4574_CR5","doi-asserted-by":"crossref","first-page":"8025951","DOI":"10.1155\/2018\/8025951","volume":"2018","author":"H Miao","year":"2018","unstructured":"Miao H, Hou X, Hwang DK, Tao Y (2018) Vascular endothelial growth factor, basic fibroblast growth factor, and pigment epithelium-derived factor expression in the neovascular iris in retinal diseases. J Ophthalmol 2018:8025951","journal-title":"J Ophthalmol"},{"issue":"1","key":"4574_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3928\/15428877-20070101-01","volume":"38","author":"XB Yu","year":"2007","unstructured":"Yu XB, Sun XH, Dahan E, Guo WY, Qian SH, Meng FR, Song YL, Simon GJ (2007) Increased levels of transforming growth factor-betal and -beta2 in the aqueous humor of patients with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 38(1):6\u201314","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"2","key":"4574_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0161-6420(98)92782-8","volume":"105","author":"RC Tripathi","year":"1998","unstructured":"Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP (1998) Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 105(2):232\u2013237","journal-title":"Ophthalmology"},{"issue":"11","key":"4574_CR8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.2337\/diacare.19.11.1306b","volume":"19","author":"H Sone","year":"1996","unstructured":"Sone H, Okuda Y, Kawakami Y, Hanatani M, Suzuki H, Kozawa T, Honmura S, Yamashita K (1996) Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated. Diabetes Care 19(11):1306\u20131307","journal-title":"Diabetes Care"},{"issue":"6","key":"4574_CR9","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1167\/iovs.14-15918","volume":"56","author":"S Ohira","year":"2015","unstructured":"Ohira S, Inoue T, Shobayashi K, Iwao K, Fukushima M, Tanihara H (2015) Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection. Invest Ophthalmol Vis Sci 56(6):3541\u20133548","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4574_CR10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1167\/iovs.14-15589","volume":"56","author":"K Ishikawa","year":"2015","unstructured":"Ishikawa K, Yoshida S, Kobayashi Y, Zhou Y, Nakama T, Nakao S, Sassa Y, Oshima Y, Niiro H, Akashi K, Kono T, Ishibashi T (2015) Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 56(2):932\u2013946","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4574_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.omtn.2017.01.004","volume":"6","author":"T Nakama","year":"2017","unstructured":"Nakama T, Yoshida S, Ishikawa K, Kubo Y, Kobayashi Y, Zhou Y, Nakao S, Hisatomi T, Ikeda Y, Takao K, Yoshikawa K, Matsuda A, Ono J, Ohta S, Izuhara K, Kudo A, Sonoda KH, Ishibashi T (2017) Therapeutic effect of novel single-stranded RNAi agent targeting periostin in eyes with retinal neovascularization. Mol Ther Nucleic Acids 6:279\u2013289","journal-title":"Mol Ther Nucleic Acids"},{"key":"4574_CR12","first-page":"436","volume":"22","author":"Y Kobayashi","year":"2016","unstructured":"Kobayashi Y, Yoshida S, Zhou Y, Nakama T, Ishikawa K, Arima M, Nakao S, Sassa Y, Takeda A, Hisatomi T, Ikeda Y, Matsuda A, Sonoda KH, Ishibashi T (2016) Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy. Mol Vis 22:436\u2013445","journal-title":"Mol Vis"},{"issue":"1","key":"4574_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1096\/fj.13-229740","volume":"28","author":"K Ishikawa","year":"2014","unstructured":"Ishikawa K, Yoshida S, Nakao S, Nakama T, Kita T, Asato R, Sassa Y, Arita R, Miyazaki M, Enaida H, Oshima Y, Murakami N, Niiro H, Ono J, Matsuda A, Goto Y, Akashi K, Izuhara K, Kudo A, Kono T, Hafezi-Moghadam A, Ishibashi T (2014) Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy. FASEB J 28(1):131\u2013142","journal-title":"FASEB J"},{"issue":"8","key":"4574_CR14","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1167\/iovs.10-6625","volume":"52","author":"S Yoshida","year":"2011","unstructured":"Yoshida S, Ishikawa K, Asato R, Arima M, Sassa Y, Yoshida A, Yoshikawa H, Narukawa K, Obika S, Ono J, Ohta S, Izuhara K, Kono T, Ishibashi T (2011) Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 52(8):5670\u20135678","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"4574_CR15","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/labinvest.2016.99","volume":"96","author":"Y Kobayashi","year":"2016","unstructured":"Kobayashi Y, Yoshida S, Zhou Y, Nakama T, Ishikawa K, Kubo Y, Arima M, Nakao S, Hisatomi T, Ikeda Y, Matsuda A, Sonoda KH, Ishibashi T (2016) Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin alphaV. Lab Investig 96(11):1178\u20131188","journal-title":"Lab Investig"},{"issue":"1","key":"4574_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2337\/db06-0581","volume":"56","author":"T Kita","year":"2007","unstructured":"Kita T, Hata Y, Kano K, Miura M, Nakao S, Noda Y, Shimokawa H, Ishibashi T (2007) Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes 56(1):231\u2013238","journal-title":"Diabetes"},{"issue":"3","key":"4574_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3341\/kjo.2006.20.3.162","volume":"20","author":"SH Min","year":"2006","unstructured":"Min SH, Lee TI, Chung YS, Kim HK (2006) Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes. Korean J Ophthalmol 20(3):162\u2013165","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"4574_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/gt.2014.112","volume":"22","author":"T Nakama","year":"2015","unstructured":"Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Zhou Y, Nakao S, Sassa Y, Oshima Y, Takao K, Shimahara A, Yoshikawa K, Hamasaki T, Ohgi T, Hayashi H, Matsuda A, Kudo A, Nozaki M, Ogura Y, Kuroda M, Ishibashi T (2015) Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. Gene Ther 22(2):127\u2013137","journal-title":"Gene Ther"},{"issue":"1","key":"4574_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12079-017-0422-6","volume":"12","author":"A Kudo","year":"2018","unstructured":"Kudo A, Kii I (2018) Periostin function in communication with extracellular matrices. J Cell Commun Signal 12(1):301\u2013308","journal-title":"J Cell Commun Signal"},{"issue":"3","key":"4574_CR20","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1074\/jbc.M109.051961","volume":"285","author":"I Kii","year":"2010","unstructured":"Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, Kudo A (2010) Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem 285(3):2028\u20132039","journal-title":"J Biol Chem"},{"issue":"1","key":"4574_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaci.2006.02.046","volume":"118","author":"G Takayama","year":"2006","unstructured":"Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, McKenzie AN, Nagai H, Hotokebuchi T, Izuhara K (2006) Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 118(1):98\u2013104","journal-title":"J Allergy Clin Immunol"},{"key":"4574_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.exer.2016.07.009","volume":"158","author":"WD Stamer","year":"2017","unstructured":"Stamer WD, Clark AF (2017) The many faces of the trabecular meshwork cell. Exp Eye Res 158:112\u2013123","journal-title":"Exp Eye Res"},{"issue":"4","key":"4574_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.exer.2008.11.023","volume":"88","author":"KE Keller","year":"2009","unstructured":"Keller KE, Aga M, Bradley JM, Kelley MJ, Acott TS (2009) Extracellular matrix turnover and outflow resistance. Exp Eye Res 88(4):676\u2013682","journal-title":"Exp Eye Res"},{"issue":"5","key":"4574_CR24","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/dvdy.21933","volume":"238","author":"RA Norris","year":"2009","unstructured":"Norris RA, Potts JD, Yost MJ, Junor L, Brooks T, Tan H, Hoffman S, Hart MM, Kern MJ, Damon B, Markwald RR, Goodwin RL (2009) Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn 238(5):1052\u20131063","journal-title":"Dev Dyn"},{"issue":"7","key":"4574_CR25","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1359\/jbmr.1999.14.7.1239","volume":"14","author":"K Horiuchi","year":"1999","unstructured":"Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A (1999) Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 14(7):1239\u20131249","journal-title":"J Bone Miner Res"},{"issue":"1","key":"4574_CR26","doi-asserted-by":"publisher","first-page":"14533","DOI":"10.1038\/s41598-018-32725-3","volume":"8","author":"I Chono","year":"2018","unstructured":"Chono I, Miyazaki D, Miyake H, Komatsu N, Ehara F, Nagase D, Kawamoto Y, Shimizu Y, Ideta R, Inoue Y (2018) High interleukin-8 level in aqueous humor is associated with poor prognosis in eyes with open angle glaucoma and neovascular glaucoma. Sci Rep 8(1):14533","journal-title":"Sci Rep"},{"issue":"9","key":"4574_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/ceo.12559","volume":"43","author":"JR SooHoo","year":"2015","unstructured":"SooHoo JR, Seibold LK, Pantcheva MB, Kahook MY (2015) Aflibercept for the treatment of neovascular glaucoma. Clin Exp Ophthalmol 43(9):803\u2013807","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04574-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04574-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04574-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T00:17:52Z","timestamp":1608337072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04574-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4574"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04574-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"20 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of the Kyushu University Hospital and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}